Acute Care, Prescription Opioid Use, and Overdose Following Discontinuation of Long-Term Buprenorphine Treatment for Opioid Use Disorder
American Journal of Psychiatry
Fecha de publicación: 2 December 2019
DOI: https://doi.org/10.1176/appi.ajp.2019.19060612
Autores: Arthur Robin Williams, M.D., M.B.E., Hillary Samples, Ph.D., Stephen Crystal, Ph.D., Mark Olfson, M.D., M.P.H.
Background: Although buprenorphine treatment reduces risk of overdose and death in opioid use disorder, most patients discontinue treatment within a few weeks or months. Adverse health outcomes following buprenorphine discontinuation were compared among patients who were successfully retained beyond 6 months of continuous treatment, a minimum treatment duration recently endorsed by the National Quality Forum.
